Search Press releases Keywords From To 17 May 2024 Acquisition of own shares Read More 14 May 2024 New data published in the Journal of Neurology show clinically meaningful improvement of fatigue in generalized myasthenia gravis (gMG) with ZILBRYSQ[®]▼ (zilucoplan) Read More 10 May 2024 Acquisition of own shares Read More 8 May 2024 UCB presents final open-label extension FINTEPLA®▼(fenfluramine)[1] data at International Child Neurology Congress (ICNC) Annual Meeting Read More 3 May 2024 Acquisition of own shares Read More 26 Apr 2024 Acquisition of own shares Read More Pagination First page Previous page Previous … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Page 27 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe